Hepadnaviruses and hepatocellular carcinoma

Current Cancer Research

Volumn 8, Issue , 2012, Pages 531-569

  Mason, William S ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; CIRCULAR DNA; HEPATITIS B VACCINE; HEPATITIS B VIRUS X PROTEIN; MESSENGER RNA; VIRUS DNA; VIRUS ENVELOPE PROTEIN; VIRUS RNA;

ANTIVIRAL THERAPY; ARTICLE; CANCER CHEMOTHERAPY; CHRONIC LIVER DISEASE; DISEASE ASSOCIATION; DNA SEQUENCE; DNA SYNTHESIS; ENDOPLASMIC RETICULUM; GENOME SIZE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INNATE IMMUNITY; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CARCINOMA; LIVER REGENERATION; MACROPHAGE; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN EXPRESSION; VACCINATION; VIRUS CARCINOGENESIS; VIRUS GENOME; VIRUS IMMUNITY; VIRUS REACTIVATION; VIRUS REPLICATION;

EID: 84870764117     PISSN: 09400745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-0016-5_22     Document Type: Article

References (320)

1. Abe K, Kurata T, Shikata T, Tennant BC (1988). Enzyme-altered liver cell foci in woodchucks infected with woodchuck hepatitis virus. Jpn J Cancer Res 79:466-472
2. Alison MR, Islam S, Lim S (2009). Stem cells in liver regeneration, fibrosis and cancer: the good, the bad and the ugly. J Pathol 217:282-298
3. Aoki N, Robinson WS (1989). State of hepatitis B viral genomes in cirrhotic and hepatocellular carcinoma nodules. Mol Biol Med 6:395-408
4. Asabe S, Wieland SF, Chattopadhyay PK, Roederer M, Engle RE, Purcell RH, Chisari FV (2009) The size of the viral inoculum contributes to the outcome of hepatitis B virus infection. J Virol 83:9652-9662
5. Aufiero B, Schneider RJ (1990). The hepatitis B virus X-gene product trans-activates both RNA polymerase II and III promoters. EMBO J 9:497-504
6. Avantaggiati ML, Natoli G, Balsano C, Chirillo P, Artini M, De Marzio E, Collepardo D, Levrero M (1993). The hepatitis B virus (HBV) pX transactivates the c-fos promoter through multiple cis-acting elements. Oncogene 8:1567-1574
7. Balsano C, Avantaggiati ML, Natoli G, De Marzio E, Will H, Perricaudet M, Levrero M (1991) Full-length and truncated versions of the hepatitis B virus (HBV) X protein (pX) transactivate the cmyc protooncogene at the transcriptional level. Biochem Biophys Res Commun 176:985-992
8. Barash H, Gross ER, Edrei Y, Ella E, Israel A, Cohen I, Corchia N, Ben-Moshe T, Pappo O, Pikarsky E, Goldenberg D, Shiloh Y, Galun E, Abramovitch R (2010). Accelerated carcinogenesis following liver regeneration is associated with chronic inflammation-induced doublestrand DNA breaks. Proc Natl Acad Sci USA 107:2207-2212
9. Barnabas S, Hai T, Andrisani OM (1997). The hepatitis B virus X protein enhances the DNA binding potential and transcription efficacy of bZip transcription factors. J Biol Chem 272:20684-20690
10. Beasley RP (1982). Hepatitis B virus as the etiologic agent in hepatocellular carcinoma: epidemiologic considerations. Hepatology 2:21S-26S
11. Beasley RP (1988). Hepatitis B virus: the major etiology of hepatocellular carcinoma. Cancer 61:1942-1956
12. Beasley RP, Lin CC, Hwang LY, Chien CS (1981). Hepatocellular carcinoma and hepatitis B virus. Lancet 2:1129-1133
13. Becker SA, Lee TH, Butel JS, Slagle BL (1998). Hepatitis B virus X protein interferes with cellular DNA repair. J Virol 72:266-272
14. Bergametti F, Prigent S, Luber B, Benoit A, Tiollais P, Sarasin A, Transy C (1999). The proapoptotic effect of hepatitis B virus HBx protein correlates with its transactivation activity in stably transfected cell lines. Oncogene 18:2860-2871
15. Bill CA, Summers J (2004). Genomic DNA double-strand breaks are targets for hepadnaviral DNA integration. Proc Natl Acad Sci USA 101:11135-11140
16. Blumberg BS, London WT (1982). Hepatitis B virus: pathogenesis and prevention of primary cancer of the liver. Cancer 50:2657-2665
17. Blumberg BS, Gerstley BJS, Hungerford DA, London WT, Sutnik AI (1967). A serum antigen (Australia antigen) in Down's syndrome, leukemia and hepatitis. Ann Intern Med 66:924-931
18. Bock CT, Schwinn S, Locarnini S, Fyfe J, Manns MP, Trautwein C, Zentgraf H (2001). Structural organization of the hepatitis B virus minichromosome. J Mol Biol 307:183-196
19. Bock CT, Toan NL, Koeberlein B, Song le H, Chin R, Zentgraf H, Kandolf R, Torresi J (2008) Subcellular mislocalization of mutant hepatitis B X proteins contributes to modulation of STAT/SOCS signaling in hepatocellular carcinoma. Intervirology 51:432-443
20. Bosch FX, Ribes J, Cleries R, Diaz M (2005). Epidemiology of hepatocellular carcinoma. Clin Liver Dis 9:191-211
21. Bouchard M, Giannakopoulos S, Wang EH, Tanese N, Schneider RJ (2001a). Hepatitis B virus HBx protein activation of cyclin A-cyclin-dependent kinase 2 complexes and G1 transit via a Src kinase pathway. J Virol 75:4247-4257
22. Bouchard MJ, Wang LH, Schneider RJ (2001b). Calcium signaling by HBx protein in hepatitis B virus DNA replication. Science 294:2376-2378
23. Brechot C, Pourcel C, Louise A, Rain B, Tiollais P (1980). Presence of integrated hepatitis B virus DNA sequences in cellular DNA of human hepatocellular carcinoma. Nature 286:533-535
24. Brechot C, Hadchouel M, Scotto J, Degos F, Charnay P, Trepo C, Tiollais P (1981a). Detection of hepatitis B virus DNA in liver and serum: a direct appraisal of the chronic carrier state. Lancet 2:765-768
25. Brechot C, Hadchouel M, Scotto J, Fonck M, Potet F, Vyas GN, Tiollais P (1981b). State of hepatitis B virus DNA in hepatocytes of patients with hepatitis B surface antigen-positive and-negative liver diseases. Proc Natl Acad Sci USA 78:3906-3910
26. Breiner KM, Schaller H, Knolle PA (2001). Endothelial cell-mediated uptake of a hepatitis B virus: a new concept of liver targeting of hepatotropic microorganisms. Hepatology 34:803-808
27. Bringas R (1997). Folding and assembly of hepatitis B virus core protein: a new model proposal. J Struct Biol 118:189-196
28. Brunetto MR, Rodriguez UA, Bonino F (1999). Hepatitis B virus mutants. Intervirology 42:69-80
29. Bruni R, D'Ugo E, Giuseppetti R, Argentini C, Rapicetta M (1999). Activation of the N-myc2 oncogene by woodchuck hepatitis virus integration in the linked downstream b3n locus in woodchuck hepatocellular carcinoma. Virology 257:483-490
30. Bruni R, D'Ugo E, Villano U, Fourel G, Buendia MA, Rapicetta M (2004). The win locus involved in activation of the distal N-myc2 gene upon WHV integration in woodchuck liver tumors harbors S/MAR elements. Virology 329:1-10
31. Bruni R, Conti I, Villano U, Giuseppetti R, Palmieri G, Rapicetta M (2006). Lack of WHV integration nearby N-myc2 and in the downstream b3n and win loci in a considerable fraction of liver tumors with activated N-myc2 from naturally infected wild woodchucks. Virology 345:258-269
32. Bruss V, Ganem D (1991). The role of envelope proteins in hepatitis B virus assembly. Proc Natl Acad Sci USA 88:1059-1063
33. Bruss V, Vieluf K (1995). Functions of the internal pre-S domain of the large surface protein in hepatitis B virus particle morphogenesis. J Virol 69:6652-6657
34. Budhu A, Forgues M, Ye QH, Jia HL, He P, Zanetti KA, Kammula US, Chen Y, Qin LX, Tang ZY, Wang XW (2006). Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment. Cancer Cell 10:99-111
35. Burrell CJ, Gowans EJ, Jilbert AR, Lake JR, Marmion BP (1982). Hepatitis B virus DNA detection by in situ cytohybridization: implications for viral replication strategy and pathogenesis of chronic hepatitis. Hepatology 2:85S-91S
36. Burrell CJ, Gowans EJ, Rowland R, Hall P, Jilbert AR, Marmion BP (1984). Correlation between liver histology and markers of hepatitis B virus replication in infected patients: a study by in situ hybridization. Hepatology 4:20-24
37. Cao F, Scougall CA, Jilbert AR, Tavis JE (2009). Pre-P is a secreted glycoprotein encoded as an N-terminal extension of the duck hepatitis B virus polymerase gene. J Virol 83:1368-1378
38. Capovilla A, Arbuthnot P (2003). Hepatitis B virus X protein does not influence essential steps of nucleotide excision repair effected by human liver extracts. Biochem Biophys Res Commun 312:806-810
39. Caselmann WH, Renner M, Schluter V, Hofschneider PH, Koshy R, Meyer M (1997). The hepatitis B virus MHBst167 protein is a pleiotropic transactivator mediating its effect via ubiquitous cellular transcription factors. J Gen Virol 78:1487-1495
40. Chang MH, You SL, Chen CJ, Liu CJ, Lee CM, Lin SM, Chu HC, Wu TC, Yang SS, Kuo HS, Chen DS, Taiwan Hepatoma Study Group (2009). Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study. J Natl Cancer Inst 101:1348-1355
41. Chen DS (2009). Hepatitis B vaccination: the key towards elimination and eradication of hepatitis B. J Hepatol 50:805-816
42. Chen J, Siddiqui A (2007). Hepatitis B virus X protein stimulates the mitochondrial translocation of Raf-1 via oxidative stress. J Virol 81:6757-6760
43. Chen M, Sallberg M, Hughes J, Jones J, Guidotti LG, Chisari FV, Billaud JN, Milich DR (2005) Immune tolerance split between hepatitis B virus precore and core proteins. J Virol 79:3016-3027
44. Chen BF, Liu CJ, Jow GM, Chen PJ, Kao JH, Chen DS (2006). High prevalence and mapping of pre-S deletion in hepatitis B virus carriers with progressive liver diseases. Gastroenterology 130:1153-1168
45. Chen CH, Hung CH, Lee CM, Hu TH, Wang JH, Wang JC, Lu SN, Changchien CS (2007). Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAgnegative patients. Gastroenterology 133:1466-1474 [see comment] Chen JD, Yang HI, Iloeje UH, You SL, Lu SN, Wang LY, Su J, Sun CA, Liaw YF, Chen CJ, Risk
46. Chen JD, Yang HI, Iloeje UH, You SL, Lu SN, Wang LY, Su J, Sun CA, Liaw YF, Chen CJ, Risk Evaluation of Viral Load Elevation and Associated Liver Disease/Cancer in HBVSG (2010) Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liverrelated death. Gastroenterology 138:1747-1754
47. Cheng P, Li Y, Yang L, Wen Y, Shi W, Mao Y, Chen P, Lv H, Tang Q, Wei Y (2009). Hepatitis B virus X protein (HBx) induces G2/M arrest and apoptosis through sustained activation of cyclin B1-CDK1 kinase. Oncol Rep 22:1101-1107
48. Chien RN, Liaw YF (2003). Short-term lamivudine therapy in patients with chronic hepatitis B. Intervirology 46:362-366
49. Chien RN, Liaw YF (2008). Nucleos(t)ide analogues for hepatitis B virus: strategies for long-term success. Best Pract Res Clin Gastroenterol 22:1081-1092
50. Chisari FV, Filippi P, Buras J, McLachlan A, Popper H, Pinkert CA, Palmiter RD, Brinster RL (1987). Structural and pathological effects of synthesis of hepatitis B virus large envelope polypeptide in transgenic mice. Proc Natl Acad Sci USA 84:6909-6913
51. Chisari FV, Klopchin K, Moriyama T, Pasquinelli C, Dunsford HA, Sell S, Pinkert CA, Brinster RL, Palmiter RD (1989). Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell 59:1145-1156
52. Clippinger AJ, Bouchard MJ (2008). Hepatitis B virus HBx protein localizes to mitochondria in primary rat hepatocytes and modulates mitochondrial membrane potential. J Virol 82:6798-6811
53. Cohen D, Adamovich Y, Reuven N, Shaul Y (2010). Hepatitis B virus activates deoxynucleotide synthesis in nondividing hepatocytes by targeting the R2 gene. Hepatology 51:1538-1546
54. Colgrove R, Simon G, Ganem D (1989). Transcriptional activation of homologous and heterologous genes by the hepatitis B virus X gene product in cells permissive for viral replication. J Virol 63:4019-4026
55. Colombo M, Sangiovanni A (2002). The European approach to hepatocellular carcinoma. Hepatogastroenterology 49:12-16
56. Connolly E, Melegari M, Landgraf P, Tchaikovskaya T, Tennant BC, Slagle BL, Rogler LE, Zavolan M, Tuschl T, Rogler CE (2008). Elevated expression of the miR-17-92 polycistron and miR-21 in hepadnavirus-associated hepatocellular carcinoma contributes to the malignant phenotype. Am J Pathol 173:856-864
57. Crawford DR, Ostrowski S, Vakharia D, Ilic Z, Sell S (2006). Separate origins of hepatitis B virus surface antigen-negative foci and hepatocellular carcinomas in transgenic HBsAg (alb/psx) mice. Am J Pathol 169:223-232
58. Cross JC, Wen P, Rutter WJ (1993). Transactivation by hepatitis B virus X protein is promiscuous and dependent on mitogen-activated cellular serine/threonine kinases. Proc Natl Acad Sci USA 90:8078-8082
59. Crowther RA, Kiselev NA, Bottcher B, Berriman JA, Borisova GP, Ose V, Pumpens P (1994) Three-dimensional structure of hepatitis B virus core particles determined by electron cryomicroscopy. Cell 77:943-950
60. Dejean A, Bougueleret L, Grzeschik KH, Tiollais P (1986). Hepatitis B virus DNA integration in a sequence homologous to v-erb-A and steroid receptor genes in a hepatocellular carcinoma. Nature 322:70-72
61. Dienstag JL, Perrillo RP, Schiff ER, Bartholomew M, Vicary C, Rubin M (1995). A preliminary trial of lamivudine for chronic hepatitis B infection. N Engl J Med 333:1657-1661 [see comments]
62. Dorjsuren D, Lin Y, Wei W, Yamashita T, Nomura T, Hayashi N, Murakami S (1998). RMP, a novel RNA polymerase II subunit 5-interacting protein, counteracts transactivation by hepatitis B virus X protein. Mol Cell Biol 18:7546-7555
63. Elmore LW, Hancock AR, Chang SF, Wang XW, Chang S, Callahan CP, Geller DA, Will H, Harris CC (1997). Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis. Proc Natl Acad Sci USA 94:14707-14712
64. Evans AA, O'Connell AP, Pugh JC, Mason WS, Shen FM, Chen GC, Lin WY, Dia A, M'Boup S, Drame B, London WT (1998). Geographic variation in viral load among hepatitis B carriers with differing risks of hepatocellular carcinoma. Cancer Epidemiol Biomarkers Prev 7:559-565
65. Evarts RP, Nagy P, Marsden E, Thorgeirsson SS (1987). A precursor-product relationship exists between oval cells and hepatocytes in rat liver. Carcinogenesis 8:1737-1740
66. Fan YF, Lu CC, Chang YC, Chang TT, Lin PW, Lei HY, Su IJ (2000). Identification of a pre-S2 mutant in hepatocytes expressing a novel marginal pattern of surface antigen in advanced diseases of chronic hepatitis B virus infection. J Gastroenterol Hepatol 15:519-528
67. Fausto N (2004). Liver regeneration and repair: hepatocytes, progenitor cells, and stem cells. Hepatology 39:1477-1486
68. Feitelson MA, Duan LX (1997). Hepatitis B virus X antigen in the pathogenesis of chronic infections and the development of hepatocellular carcinoma. Am J Pathol 150:1141-1157
69. Feitelson MA, Reis HM, Tufan NL, Sun B, Pan J, Lian Z (2009). Putative roles of hepatitis B x antigen in the pathogenesis of chronic liver disease. Cancer Lett 286:69-79
70. Fernholz D, Galle PR, Stemler M, Brunetto M, Bonino F, Will H (1993). Infectious hepatitis B virus variant defective in pre-S2 protein expression in a chronic carrier. Virology 194:137-148
71. Flajolet M, Tiollais P, Buendia MA, Fourel G (1998). Woodchuck hepatitis virus enhancer I and enhancer II are both involved in N-myc2 activation in woodchuck liver tumors. J Virol 72:6175-6180
72. Foo NC, Yen TS (2000). Activation of promoters for cellular lipogenic genes by hepatitis B virus large surface protein. Virology 269:420-425
73. Fourel G, Trepo C, Bougueleret L, Henglein B, Ponzetto A, Tiollais P, Buendia MA (1990) Frequent activation of N-myc genes by hepadnavirus insertion in woodchuck liver tumours. Nature 347:294-298
74. Fourel G, Couturier J, Wei Y, Apiou F, Tiollais P, Buendia MA (1994). Evidence for long-range oncogene activation by hepadnavirus insertion. EMBO J 13:2526-2534
75. Frelin L, Wahlstrom T, Tucker AE, Jones J, Hughes J, Lee BO, Billaud JN, Peters C, Whitacre D, Peterson D, Milich DR (2009). A mechanism to explain the selection of the hepatitis e antigennegative mutant during chronic hepatitis B virus infection. J Virol 83:1379-1392
76. Friedrich B, Wollersheim M, Brandenburg B, Foerste R, Will H, Hildt E (2005). Induction of antiproliferative mechanisms in hepatitis B virus producing cells. J Hepatol 43:696-703
77. Fung SK, Andreone P, Han SH, Reddy RK, Regev A, Keeffe EB, Hussain M, Cusraro C, Richtmyer P, Marrero JA, Lok AS (2005). Adefovir-resistant hepatitis B can be associated with viral rebound and hepatic decompensation. J Hepatol 43:937-943
78. Furuya K, Nakamura M, Yamamoto T, Togel K, Otsuka H (1988). Macroregenerative nodule of the liver. A clinicopathologic study of 345 autopsy cases of chronic liver disease. Cancer 61:99-105
79. Ganem D, Prince AM (2004). Hepatitis B virus infection-natural history and clinical consequences. N Engl J Med 350:1118-1129
80. Gearhart TL, Bouchard MJ (2010). The hepatitis B virus X protein modulates hepatocyte proliferation pathways to stimulate viral replication. J Virol 84:2675-2686
81. Gehrke R, Brauchle MA, Reifenberg K, Hildt E, Gruetzner U, Schmitz V, Schlicht HJ, Hofschneider PH, Caselmann WH, Rabe C (2004). Accumulation of 8-hydroxy-2'-deoxyguanosine adducts in HBx recombinant HepG2 cells and HBx transgenic mice. Digestion 70:117-126
82. Gerber MA, Hadziyannis S, Vernace S, Vissoulis C (1975). Incidence and nature of cytoplasmic hepatitis B antigen in hepatocytes. Lab Invest 32:251-256
83. Gong SS, Jensen AD, Rogler CE (1996). Loss and acquisition of duck hepatitis B virus integrations in lineages of LMH-D2 chicken hepatoma cells. J Virol 70:2000-2007
84. Gong SS, Jensen AD, Chang CJ, Rogler CE (1999). Double-stranded linear duck hepatitis B virus (DHBV) stably integrates at a higher frequency than wild-type DHBV in LMH chicken hepatoma cells. J Virol 73:1492-1502
85. Govindarajan S, Conrad A, Lim B, Valinluck B, Kim AM, Schmid P (1990). Study of preneoplastic changes in liver cells by immunohistochemical and molecular hybridization techniques. Arch Path Lab Med 114:1042-1045
86. Gowans EJ, Burrell CJ, Jilbert AR, Marmion BP (1981). Detection of hepatitis B virus DNA sequences in infected hepatocytes by in situ cytohybridisation. J Med Virol 8:67-78
87. Greenblatt MS, Feitelson MA, Zhu M, Bennett WP, Welsh JA, Jones R, Borkowski A, Harris CC (1997). Integrity of p53 in hepatitis B x antigen-positive and-negative hepatocellular carcinomas. Cancer Res 57:426-432
88. Groisman IJ, Koshy R, Henkler F, Groopman JD, Alaoui-Jamali MA (1999). Downregulation of DNA excision repair by the hepatitis B virus-x protein occurs in p53-proficient and p53-deficient cells. Carcinogenesis 20:479-483
89. Groopman JD, Kensler TW, Wild CP (2008). Protective interventions to prevent aflatoxin-induced carcinogenesis in developing countries. Annu Rev Public Health 29:187-203
90. Gunther S, Paulij W, Meisel H, Will H (1998). Analysis of hepatitis B virus populations in an interferon-alpha-treated patient reveals predominant mutations in the C-gene and changing e-antigenicity. Virology 244:146-160
91. Gunther S, Fischer L, Pult I, Sterneck M, Will H (1999). Naturally occurring variants of hepatitis B virus. Adv Virus Res 52:25-137
92. Guo H, Mason WS, Aldrich CE, Saputelli JR, Miller DS, Jilbert AR, Newbold JE (2005) Identification and characterization of avihepadnaviruses isolated from exotic anseriformes maintained in captivity. J Virol 79:2729-2742
93. Hagen TM, Huang S, Curnutte J, Fowler P, Martinez V, Wehr CM, Ames BN, Chisari FV (1994) Extensive oxidative DNA damage in hepatocytes of transgenic mice with chronic active hepatitis destined to develop hepatocellular carcinoma. Proc Natl Acad Sci USA 91:12808-12812
94. Halpern MS, England JM, Deery DT, Petcu DJ, Mason WS, Molnar-Kimber KL (1983). Viral nucleic acid synthesis and antigen accumulation in pancreas and kidney of Pekin ducks infected with duck hepatitis B virus. Proc Natl Acad Sci USA 80:4865-4869
95. Hansen LJ, Tennant BC, Seeger C, Ganem D (1993). Differential activation of myc gene family members in hepatic carcinogenesis by closely related hepatitis B viruses. Mol Cell Biol 13:659-667
96. Haviv I, Shamay M, Doitsh G, Shaul Y (1998). Hepatitis B virus pX targets TFIIB in transcription coactivation. Mol Cell Biol 18:1562-1569
97. Hayward WS, Neel BG, Astrin SM (1981). Activation of a cellular onc gene by promoter insertion in ALV-induced lymphoid leukosis. Nature 290:475-480
98. Heermann KH, Goldmann U, Schwartz W, Seyffarth T, Baumgarten H, Gerlich WH (1984). Large surface proteins of hepatitis B virus containing the pre-s sequence. J Virol 52:396-402
99. Henkler F, Hoare J, Waseem N, Goldin RD, McGarvey MJ, Koshy R, King IA (2001). Intracellular localization of the hepatitis B virus HBx protein. J Gen Virol 82:871-882
100. Hildt E, Saher G, Bruss V, Hofschneider PH (1996). The hepatitis B virus large surface protein (LHBs) is a transcriptional activator. Virology 225:235-239
101. Hildt E, Munz B, Saher G, Reifenberg K, Hofschneider PH (2002). The PreS2 activator MHBs(t) of hepatitis B virus activates c-raf-1/Erk2 signaling in transgenic mice. EMBO J 21:525-535
102. Honkoop P, de Man RA, Niesters HG, Zondervan PE, Schalm SW (2000). Acute exacerbation of chronic hepatitis B virus infection after withdrawal of lamivudine therapy. Hepatology 32:635-639
103. Hoofnagle JH (2009). Reactivation of hepatitis B. Hepatology 49:S156-S165
104. Hoshida Y, Villanueva A, Kobayashi M, Peix J, Chiang DY, Camargo A, Gupta S, Moore J, Wrobel MJ, Lerner J, Reich M, Chan JA, Glickman JN, Ikeda K, Hashimoto M, Watanabe G, Daidone MG, Roayaie S, Schwartz M, Thung SN, Salvesen HB, Gabriel S, Mazzaferro V, Bruix J, Friedman SL, Kumada H, Llovet JM, Golub TR (2008). Gene expression in fixed tissues and outcome of hepatocellular carcinoma. N Engl J Med 359:1995-2004
105. Hsia CC, Evarts RP, Nakatsukasa H, Marsden ER, Thorgeirsson SS (1992). Occurrence of oval-type cells in hepatitis B virus-associated human hepatocarcinogenesis. Hepatology 16:1327-1333
106. Hsia CC, Thorgeirsson SS, Tabor E (1994). Expression of hepatitis B surface and core antigens and transforming growth factor-alpha in "oval cells" of the liver in patients with hepatocellular carcinoma. J Med Virol 43:216-221
107. Hsieh YH, Su IJ, Wang HC, Chang WW, Lei HY, Lai MD, Chang WT, Huang W (2004). Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage. Carcinogenesis 25:2023-2032
108. Hsieh YH, Su IJ, Wang HC, Tsai JH, Huang YJ, Chang WW, Lai MD, Lei HY, Huang W (2007) Hepatitis B virus pre-S2 mutant surface antigen induces degradation of cyclin-dependent kinase inhibitor p27Kip1 through c-Jun activation domain-binding protein. Mol Cancer Res 5:1063-1072
109. Hsu HC, Wu TT, Sheu JC, Wu CY, Chiou TJ, Lee CS, Chen DS (1989). Biologic significance of the detection of HBsAg and HBcAg in liver and tumor from 204 HBsAg-positive patients with primary hepatocellular carcinoma. Hepatology 9:747-750
110. Hu J, Seeger C (1996). Hsp90 is required for the activity of a hepatitis B virus reverse transcriptase. Proc Natl Acad Sci USA 93:1060-1064
111. Hu J, Toft DO, Seeger C (1997). Hepadnavirus assembly and reverse transcription require a multicomponent chaperone complex which is incorporated into nucleocapsids. EMBO J 16:59-68
112. Huang SN, Chisari FV (1995). Strong, sustained hepatocellular proliferation precedes hepatocarcinogenesis in hepatitis B surface antigen transgenic mice. Hepatology 21:620-626
113. Huang ZM, Tan T, Yoshida H, Mori K, Ma Y, Yen TS (2005). Activation of hepatitis B virus S promoter by a cell type-restricted IRE1-dependent pathway induced by endoplasmic reticulum stress. Mol Cell Biol 25:7522-7533
114. Jaitovich-Groisman I, Benlimame N, Slagle BL, Perez MH, Alpert L, Song DJ, Fotouhi-Ardakani N, Galipeau J, Alaoui-Jamali MA (2001). Transcriptional regulation of the TFIIH transcription repair components XPB and XPD by the hepatitis B virus x protein in liver cells and transgenic liver tissue. J Biol Chem 276:14124-14132
115. Jansen RW, Johnson LC, Averett DR (1993). High-capacity in vitro assessment of anti-hepatitis B virus compound selectivity by a virion-specific polymerase chain reaction assay. Antimicrob Agents Chemother 37:441-447
116. Ji F, Zhou L, Ma S, Li F, Ding H, Zeng C (2009). Dynamic changes of HBV quasispecies and deletion patterns in a chronic hepatitis B patient. J Med Virol 81:1551-1559
117. Jia L, Wang XW, Harris CC (1999). Hepatitis B virus X protein inhibits nucleotide excision repair. Int J Cancer 80:875-879
118. Jilbert AR, Freiman JS, Burrell CJ, Holmes M, Gowans EJ, Rowland R, Hall P, Cossart YE (1988) Virus-liver cell interactions in duck hepatitis B virus infection. A study of virus dissemination within the liver. Gastroenterology 95:1375-1382
119. Junker-Niepmann M, Bartenschlager R, Schaller H (1990). A short cis-acting sequence is required for hepatitis B virus pregenome encapsidation and sufficient for packaging of foreign RNA. EMBO J 9:3389-3396
120. Kajino K, Jilbert AR, Saputelli J, Aldrich CE, Cullen J, Mason WS (1994). Woodchuck hepatitis virus infections: very rapid recovery after a prolonged viremia and infection of virtually every hepatocyte. J Virol 68:5792-5803
121. Keasler VV, Hodgson AJ, Madden CR, Slagle BL (2009). Hepatitis B virus HBx protein localized to the nucleus restores HBx-deficient virus replication in HepG2 cells and in vivo in hydrodynamically-injected mice. Virology 390:122-129
122. Kekule AS, Lauer U, Meyer M, Caselmann WH, Hofschneider PH, Koshy R (1990). The preS2/S region of integrated hepatitis B virus DNA encodes a transcriptional transactivator. Nature 343:457-461
123. Kim CM, Koike K, Saito I, Miyamura T, Jay G (1991). HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 351:317-320
124. Kim S, Park SY, Yong H, Famulski JK, Chae S, Lee JH, Kang CM, Saya H, Chan GK, Cho H (2008). HBV X protein targets hBubR1, which induces dysregulation of the mitotic checkpoint. Oncogene 27:3457-3464
125. Koike K (2009). Hepatitis B virus X gene is implicated in liver carcinogenesis. Cancer Lett 286:60-68
126. Koike K, Moriya K, Iino S, Yotsuyanagi H, Endo Y, Miyamura T, Kurokawa K (1994). High-level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice. Hepatology 19:810-819
127. Kong HJ, Hong SH, Lee MY, Kim HD, Lee JW, Cheong J (2000). Direct binding of hepatitis B virus X protein and retinoid X receptor contributes to phosphoenolpyruvate carboxykinase gene transactivation. FEBS Lett 483:114-118
128. Kong HJ, Park MJ, Hong S, Yu HJ, Lee YC, Choi YH, Cheong J (2003). Hepatitis B virus X protein regulates transactivation activity and protein stability of the cancer-amplified transcription coactivator ASC-2. Hepatology 38:1258-1266
129. Lai CL, Chien RN, Leung NW, Chang TT, Guan R, Tai DI, Ng KY, Wu PC, Dent JC, Barber J, Stephenson SL, Gray DF (1998). A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group. N Engl J Med 339:61-68 [see comment]
130. Lanford RE, Chavez D, Brasky KM, Burns RB 3rd, Rico-Hesse R (1998). Isolation of a hepadnavirus from the woolly monkey, a New World primate. Proc Natl Acad Sci USA 95:5757-5761
131. Lara-Pezzi E, Majano PL, Yanez-Mo M, Gomez-Gonzalo M, Carretero M, Moreno-Otero R, Sanchez-Madrid F, Lopez-Cabrera M (2001a). Effect of the hepatitis B virus HBx protein on integrin-mediated adhesion to and migration on extracellular matrix. J Hepatol 34:409-415
132. Lara-Pezzi E, Roche S, Andrisani OM, Sanchez-Madrid F, Lopez-Cabrera M (2001b). The hepatitis B virus HBx protein induces adherens junction disruption in a src-dependent manner. Oncogene 20:3323-3331
133. Lauer U, Weiss L, Hofschneider PH, Kekule AS (1992). The hepatitis B virus pre-S/S(t) transactivator is generated by 3 ¢ truncations within a defined region of the S gene. J Virol 66:5284-5289
134. Lavanchy D (2004). Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 11:97-107
135. Lee SG, Rho HM (2000). Transcriptional repression of the human P53 gene by hepatitis B viral X protein. Oncogene 19:468-471
136. Lee TH, Finegold MJ, Shen RF, DeMayo JL, Woo SL, Butel JS (1990). Hepatitis B virus transactivator X protein is not tumorigenic in transgenic mice. J Virol 64:5939-5947
137. Lee YI, Hur GM, Suh DJ, Kim SH (1996). Novel pre-C/C gene mutants of hepatitis B virus in chronic active hepatitis: naturally occurring escape mutants. J Gen Virol 77:1129-1138
138. Lee S, Tarn C, Wang WH, Chen S, Hullinger RL, Andrisani OM (2002). Hepatitis B virus X protein differentially regulates cell cycle progression in X-transforming versus nontransforming hepatocyte (AML12) cell lines. J Biol Chem 277:8730-8740
139. Lee JS, Chu IS, Heo J, Calvisi DF, Sun Z, Roskams T, Durnez A, Demetris AJ, Thorgeirsson SS (2004). Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling. Hepatology 40:667-676
140. Lee YH, Oh BK, Yoo JE, Yoon SM, Choi J, Kim KS, Park YN (2009). Chromosomal instability, telomere shortening, and inactivation of p21(WAF1/CIP1) in dysplastic nodules of hepatitis B virus-associated multistep hepatocarcinogenesis. Mod Pathol 22:1121-1131
141. Lenhoff RJ, Luscombe CA, Summers J (1998). Competition in vivo between a cytopathic variant and a wild-type duck hepatitis B virus. Virology 251:85-95
142. Levrero M, Pollicino T, Petersen J, Belloni L, Raimondo G, Dandri M (2009). Control of cccDNA function in hepatitis B virus infection. J Hepatol 51:581-592
143. Li SK, Ho SF, Tsui KW, Fung KP, Waye MY (2008). Identification of functionally important amino acid residues in the mitochondria targeting sequence of hepatitis B virus X protein. Virology 381:81-88
144. Li T, Robert EI, van Breugel PC, Strubin M, Zheng N (2010). A promiscuous alpha-helical motif anchors viral hijackers and substrate receptors to the CUL4-DDB1 ubiquitin ligase machinery. Nat Struct Mol Biol 17:105-111
145. Liang X, Liu Y, Zhang Q, Gao L, Han L, Ma C, Zhang L, Chen YH, Sun W (2007). Hepatitis B virus sensitizes hepatocytes to TRAIL-induced apoptosis through Bax. J Immunol 178:503-510
146. Liaw YF (2009). Natural history of chronic hepatitis B virus infection and long-term outcome under treatment. Liver Int 29:S100-S107.
147. Liaw YF, Sung JJ, Chow WC, Farrell G, Lee CZ, Yuen H, Tanwandee T, Tao QM, Shue K, Keene ON, Dixon JS, Gray DF, Sabbat J, Cirrhosis Asian Lamivudine Multicentre Study Group (2004) Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med 351:1521-1531.
148. Libbrecht L, Desmet V, Van Damme B, Roskams T (2000). Deep intralobular extension of human hepatic 'progenitor cells' correlates with parenchymal inflammation in chronic viral hepatitis: can 'progenitor cells' migrate? J Pathol 192:373-378
149. Lim W, Kwon SH, Cho H, Kim S, Lee S, Ryu WS (2010). HBx targeting to mitochondria and ROS generation are necessary but insufficient for HBV-induced cyclooxygenase-2 expression. J Mol Med 88:359-369
150. Lin Y, Nomura T, Cheong J, Dorjsuren D, Iida K, Murakami S (1997). Hepatitis B virus X protein is a transcriptional modulator that communicates with transcription factor IIB and the RNA polymerase II subunit 5. J Biol Chem 272:7132-7139
151. Ling R, Harrison TJ (1997). Production of hepatitis B virus covalently closed circular DNA in transfected cells is independent of surface antigen synthesis. J Gen Virol 78:1463-1467
152. Locarnini S, Mason WS (2005). Cellular and virological mechanisms of HBV drug resistance. J Hepatol 44:422-431
153. Lok ASF, McMahon BJ (2007). Chronic hepatitis B: AAALD practice guidelines. Hepatology 45:507-539
154. Lucito R, Schneider RJ (1992). Hepatitis B virus X protein activates transcription factor NF-kappa B without a requirement for protein kinase C. J Virol 66:983-991
155. Lupberger J, Hildt E (2007). Hepatitis B virus-induced oncogenesis. World J Gastroenterol 13:74-81
156. Ma NF, Lau SH, Hu L, Xie D, Wu J, Yang J, Wang Y, Wu MC, Fung J, Bai X, Tzang CH, Fu L, Yang M, Su YA, Guan XY (2008). COOH-terminal truncated HBV X protein plays key role in hepatocarcinogenesis. Clin Cancer Res 14:5061-5068
157. Madden CR, Slagle BL (2001). Stimulation of cellular proliferation by hepatitis B virus X protein. Dis Markers 17:153-157
158. Madden CR, Finegold MJ, Slagle BL (2001). Hepatitis B virus X protein acts as a tumor promoter in development of diethylnitrosamine-induced preneoplastic lesions. J Virol 75:3851-3858
159. Maeda S, Kamata H, Luo JL, Leffert H, Karin M (2005). IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell 121:977-990
160. Maguire HF, Hoeffler JP, Siddiqui A (1991). HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interactions. Science 252:842-844
161. Mahe Y, Mukaida N, Kuno K, Akiyama M, Ikeda N, Matsushima K, Murakami S (1991). Hepatitis B virus X protein transactivates human interleukin-8 gene through acting on nuclear factor kB and CCAAT/enhancer-binding protein-like cis-elements. J Biol Chem 266:13759-13763
162. Marinos G, Torre F, Gunther S, Thomas MG, Will H, Williams R, Naoumov NV (1996). Hepatitis B virus variants with core gene deletions in the evolution of chronic hepatitis B infection. Gastroenterology 111:183-192
163. Marion PL, Oshiro LS, Regnery DC, Scullard GH, Robinson WS (1980). A virus in Beechey ground squirrels that is related to hepatitis B virus of humans. Proc Natl Acad Sci USA 77:2941-2945
164. Marongiu F, Doratiotto S, Montisci S, Pani P, Laconi E (2008). Liver repopulation and carcinogenesis: two sides of the same coin? Am J Pathol 172:857-864
165. Martin-Lluesma S, Schaeffer C, Robert EI, van Breugel PC, Leupin O, Hantz O, Strubin M (2008) Hepatitis B virus X protein affects S phase progression leading to chromosome segregation defects by binding to damaged DNA binding protein 1. Hepatology 48:1467-1476
166. Martin-Vilchez S, Sanz-Cameno P, Rodriguez-Munoz Y, Majano PL, Molina-Jimenez F, Lopez-Cabrera M, Moreno-Otero R, Lara-Pezzi E (2008). The hepatitis B virus X protein induces paracrine activation of human hepatic stellate cells. Hepatology 47:1872-1883
167. Mashal RD, Lester SC, Sklar J (1993). Clonal analysis by study of X chromosome inactivation in formalin-fixed paraffin-embedded tissue. Cancer Res 53:4676-4679
168. Mason WS, Seal G, Summers J (1980). Virus of Pekin ducks with structural and biological relatedness to human hepatitis B virus. J Virol 36:829-836
169. Mason WS, Cullen J, Moraleda G, Saputelli J, Aldrich CE, Miller DS, Tennant B, Frick L, Averett D, Condreay LD, Jilbert AR (1998). Lamivudine therapy of WHV-infected woodchucks. Virology 245:18-32
170. Mason WS, Jilbert AR, Summers J (2005). Clonal expansion of hepatocytes during chronic woodchuck hepatitis virus infection. Proc Natl Acad Sci USA 102:1139-1144
171. Mason WS, Litwin S, Jilbert AR (2008). Immune selection during chronic hepadnavirus infection. Hepatol Int 2:3-16
172. Mason WS, Low H-C, Xu C, Aldrich CE, Scougall CA, Grosse A, Clouston A, Chavez D, Litwin S, Peri S, Jilbert AR, Lanford RE (2009). Detection of clonally expanded hepatocytes in chimpanzees with chronic hepatitis B virus infection. J Virol 83:8396-8408
173. Mason WS, Liu C, Aldrich CE, Litwin S, Yeh MM (2010). Clonal expansion of normal appearing human hepatocytes during chronic HBV infection. J Virol 84:8308-8315
174. Mathonnet G, Lachance S, Alaoui-Jamali M, Drobetsky EA (2004). Expression of hepatitis B virus X oncoprotein inhibits transcription-coupled nucleotide excision repair in human cells. Mutat Res 554:305-318
175. McAuliffe VJ, Purcell RH, Gerin JL (1980). Type B hepatitis: a review of current prospects for a safe and effective vaccine. Rev Infect Dis 2:470-492
176. McLachlan A, Milich DR, Raney AK, Riggs MG, Hughes JL, Sorge J, Chisari FV (1987) Expression of hepatitis B virus surface and core antigens: influences of pre-S and precore sequences. J Virol 61:683-692
177. Milich DR, Jones J, Hughes J, Maruyama T (1993). Role of T-cell tolerance in the persistence of hepatitis B virus infection. J Immunother Emphasis Tumor Immunol 14:226-233
178. Mulrooney-Cousins PM, Michalak TI (2007). Persistent occult hepatitis B virus infection: experimental findings and clinical implications. World J Gastroenterol 13:5682-5686
179. Murakami Y, Saigo K, Takashima H, Minami M, Okanoue T, Brechot C, Paterlini-Brechot P (2005). Large scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related hepatocellular carcinomas. Gut 54:1162-1168
180. Murata M, Matsuzaki K, Yoshida K, Sekimoto G, Tahashi Y, Mori S, Uemura Y, Sakaida N, Fujisawa J, Seki T, Kobayashi K, Yokote K, Koike K, Okazaki K (2009). Hepatitis B virus X protein shifts human hepatic transforming growth factor (TGF)-beta signaling from tumor suppression to oncogenesis in early chronic hepatitis B. Hepatology 49:1203-1217
181. Myerson RM, Soroush A, Skerrett PV (1971). Hepatocellular carcinoma, positive Australia (hepatitisassociated) antigen and sarcoidosis. Am J Dig Dis 16:857-862
182. Nakabayashi H, Taketa K, Miyano K, Yamane T, Sato J (1982). Growth of human hepatoma cell line with differentiated functions in chemically defined medium. Cancer Res 42:3858-3863
183. Nakamoto Y, Guidotti LG, Kuhlen CV, Fowler P, Chisari FV (1998). Immune pathogenesis of hepatocellular carcinoma. J Exp Med 188:341-350
184. Nayak NC, Dhar A, Sachdeva R, Mittal A, Seth HN, Sudarsanam D, Reddy B, Wagholikar UL, Reddy CRRM (1977). Association of human hepatocellular carcinoma and cirrhosis with hepatitis B virus surface and core antigens in the liver. Int J Cancer 20:643-654
185. Neuveut C, Wei Y, Buendia MA (2010). Mechanisms of HBV-related hepatocarcinogenesis. J Hepatol 52:594-604
186. Newbold JE, Xin H, Tencza M, Sherman G, Dean J, Bowden S, Locarnini S (1995). The covalently closed duplex form of the hepadnavirus genome exists in situ as a heterogeneous population of viral minichromosomes. J Virol 69:3350-3357
187. Nowak MA, Bonhoeffer S, Hill AM, Boehme R, Thomas HC, McDade H (1996). Viral dynamics in hepatitis B virus infection. Proc Natl Acad Sci USA 93:4398-4402
188. Oertel M, Menthena A, Chen YQ, Teisner B, Jensen CH, Shafritz DA (2008). Purification of fetal liver stem/progenitor cells containing all the repopulation potential for normal adult rat liver. Gastroenterology 134:823-832
189. Okamoto H, Tsuda F, Akahane Y, Sugai Y, Yoshiba M, Moriyama K, Tanaka T, Miyakawa Y, Mayumi M (1994). Hepatitis B virus with mutations in the core promoter for an e antigennegative phenotype in carriers with antibody to e antigen. J Virol 68:8102-8110
190. Ostapchuk P, Hearing P, Ganem D (1994). A dramatic shift in the transmembrane topology of a viral envelope glycoprotein accompanies hepatitis B viral morphogenesis. EMBO J 13:1048-1057
191. Ou JH, Rutter WJ (1987). Regulation of secretion of the hepatitis B virus major surface antigen by the preS-1 protein. J Virol 61:782-786
192. Pan J, Duan LX, Sun BS, Feitelson MA (2001). Hepatitis B virus X protein protects against anti-Fas-mediated apoptosis in human liver cells by inducing NF-kappa B. J Gen Virol 82:171-182
193. Paradis V, Laurendeau I, Vidaud M, Bedossa P (1998). Clonal analysis of macronodules in cirrhosis. Hepatology 28:953-958
194. Parekh S, Zoulim F, Ahn SH, Tsai A, Li J, Kawai S, Khan N, Trepo C, Wands J, Tong S (2003) Genome replication, virion secretion, and e antigen expression of naturally occurring hepatitis B virus core promoter mutants. J Virol 77:6601-6612
195. Park US, Park SK, Lee YI, Park JG (2000). Hepatitis B virus-X protein upregulates the expression of p21waf1/cip1 and prolongs G1->S transition via a p53-independent pathway in human hepatoma cells. Oncogene 19:3384-3394
196. Paterlini-Brechot P, Saigo K, Murakami Y, Chami M, Gozuacik D, Mugnier C, Lagorce D, Brechot C (2003). Hepatitis B virus-related insertional mutagenesis occurs frequently in human liver cancers and recurrently targets human telomerase gene. Oncogene 22:3911-3916
197. Piao Z, Park YN, Kim H, Park C (1997). Clonality of large regenerative nodules in liver cirrhosis. Liver 17:251-256
198. Pineau P, Marchio A, Battiston C, Cordina E, Russo A, Terris B, Qin LX, Turlin B, Tang ZY, Mazzaferro V, Dejean A (2008). Chromosome instability in human hepatocellular carcinoma depends on p53 status and aflatoxin exposure. Mutat Res 653:6-13
199. Ponder KP (1996). Analysis of liver development, regeneration, and carcinogenesis by genetic marking studies. FASEB J 10:673-682
200. Prassolov A, Hohenberg H, Kalinina T, Schneider C, Cova L, Krone O, Frolich K, Will H, Sirma H (2003). New hepatitis B virus of cranes that has an unexpected broad host range. J Virol 77:1964-1976
201. Preikschat P, Gunther S, Reinhold S, Will H, Budde K, Neumayer HH, Kruger DH, Meisel H (2002). Complex HBV populations with mutations in core promoter, C gene, and pre-S region are associated with development of cirrhosis in long-term renal transplant recipients. Hepatology 35:466-477
202. Pult I, Netter HJ, Bruns M, Prassolov A, Sirma H, Hohenberg H, Chang SF, Frolich K, Krone O, Kaleta EF, Will H (2001). Identification and analysis of a new hepadnavirus in white storks. Virology 289:114-128
203. Qadri I, Maguire HF, Siddiqui A (1995). Hepatitis B virus transactivator protein X interacts with the TATA-binding protein. Proc Natl Acad Sci USA 92:1003-1007
204. Qadri I, Conaway JW, Conaway RC, Schaack J, Siddiqui A (1996). Hepatitis B virus transactivator protein, HBx, associates with the components of TFIIH and stimulates the DNA helicase activity of TFIIH. Proc Natl Acad Sci USA 93:10578-10583
205. Rabe B, Delaleau M, Bischof A, Foss M, Sominskaya I, Pumpens P, Cazenave C, Castroviejo M, Kann M (2009). Nuclear entry of hepatitis B virus capsids involves disintegration to protein dimers followed by nuclear reassociation to capsids. PLoS Pathog 5:e1000563
206. Radaeva S, Li Y, Hacker HJ, Burger V, Kopp-Schneider A, Bannasch P (2000). Hepadnaviral hepatocarcinogenesis: in situ visualization of viral antigens, cytoplasmic compartmentation, enzymic patterns, and cellular proliferation in preneoplastic hepatocellular lineages in woodchucks. J Hepatol 33:580-600
207. Rahmani Z, Huh KW, Lasher R, Siddiqui A (2000). Hepatitis B virus X protein colocalizes to mitochondria with a human voltage-dependent anion channel, HVDAC3, and alters its transmembrane potential. J Virol 74:2840-2846
208. Rakotomalala L, Studach L, Wang WH, Gregori G, Hullinger RL, Andrisani O (2008). Hepatitis B virus X protein increases the Cdt1-to-geminin ratio inducing DNA re-replication and polyploidy. J Biol Chem 283:28729-28740
209. Reaiche GY, Le Mire MF, Mason WS, Jilbert AR (2010). The persistence in the liver of residual duck hepatitis B virus covalently closed circular DNA is not dependent upon new viral DNA synthesis. Virology 406(2):286-292
210. Rehermann B, Ferrari C, Pasquinelli C, Chisari FV (1996a). The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nat Med 2:1104-1108
211. Rehermann B, Lau D, Hoofnagle JH, Chisari FV (1996b). Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection. J Clin Invest 97:1655-1665
212. Renard CA, Fourel G, Bralet MP, Degott C, De La Coste A, Perret C, Tiollais P, Buendia MA (2000). Hepatocellular carcinoma in WHV/N-myc2 transgenic mice: oncogenic mutations of beta-catenin and synergistic effect of p53 null alleles. Oncogene 19:2678-2686
213. Robinson WS, Klote L, Aoki N (1990). Hepadnaviruses in cirrhotic liver and hepatocellular carcinoma. J Med Virol 31:18-32
214. Rogler CE (1991). Cellular and molecular mechanisms of hepatocarcinogenesis associated with hepadnavirus infection. Curr Top Microbiol Immunol 168:103-140
215. Roskams T (2006). Liver stem cells and their implications in hepatocellular and cholangiocarcinoma. Oncogene 25:3818-3822
216. Rountree CB, Ding W, He L, Stiles B (2009). Expansion of CD133-expressing liver cancer stem cells in liver-specific phosphatase and tensin homolog deleted on chromosome 10-deleted mice. Stem Cells 27:290-299
217. Rui E, Moura PR, Goncalves KA, Rooney RJ, Kobarg J (2006). Interaction of the hepatitis B virus protein HBx with the human transcription regulatory protein p120E4F in vitro. Virus Res 115:31-42
218. Santantonio T, Jung MC, Schneider R, Fernholz D, Milella M, Monno L, Pastore G, Pape GR, Will H (1992). Hepatitis B virus genomes that cannot synthesize pre-S2 proteins occur frequently and as dominant virus populations in chronic carriers in Italy. Virology 188:948-952
219. Sato S, Suzuki K, Akahane Y, Akamatsu K, Akiyama K, Yunomura K, Tsuda F, Tanaka T, Okamoto H, Miyakawa Y, Mayumi M (1995). Hepatitis B virus strains with mutations in the core promoter in patients with fulminant hepatitis. Ann Intern Med 122:241-248
220. Schuster R, Gerlich WH, Schaefer S (2000). Induction of apoptosis by the transactivating domains of the hepatitis B virus X gene leads to suppression of oncogenic transformation of primary rat embryo fibroblasts. Oncogene 19:1173-1180
221. Seeger C, Zoulim F, Mason WS (2006). Hepadnaviruses. In: Fields virology. Lippincott, Williams & Wilkins, pp 2977-3030.
222. Sell S, Hunt JM, Knoll BJ, Dunsford HA (1987). Cellular events during hepatocarcinogenesis and the question of premalignancy. Adv Cancer Res 48:37-111
223. Sen N, Cao F, Tavis JE (2004). Translation of duck hepatitis B virus reverse transcriptase by ribosomal shunting. J Virol 78:11751-11757
224. Seo JH, Kim KW, Murakami S, Park BC (1997). Lack of colocalization of HBxAg and insulin like growth factor II in the livers of patients with chronic hepatitis B, cirrhosis and hepatocellular carcinoma. J Korean Med Sci 12:523-531
225. Seto E, Mitchell PJ, Yen TS (1990). Transactivation by the hepatitis B virus X protein depends on AP-2 and other transcription factors. Nature 344:72-74
226. Shafritz DA, Kew MC (1981). Identification of integrated hepatitis B virus DNA sequences in human hepatocellular carcinomas. Hepatology 1:1-8
227. Shafritz DA, Shouval D, Sherman HI, Hadziyannis SJ, Kew MC (1981). Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. Studies in percutaneous liver biopsies and post-mortem tissue specimens. N Engl J Med 305:1067-1073
228. Shamay M, Barak O, Doitsh G, Ben-Dor I, Shaul Y (2002). Hepatitis B virus pX interacts with HBXAP, a PHD finger protein to coactivate transcription. J Biol Chem 277:9982-9988
229. Shera KA, Shera CA, McDougal JK (2001). Small tumor virus genomes are integrated near nuclear matrix attachment regions in transformed cells. J Virol 75:12339-12346
230. Shirakata Y, Koike K (2003). Hepatitis B virus X protein induces cell death by causing loss of mitochondrial membrane potential. J Biol Chem 278:22071-22078
231. Shirakata Y, Kawada M, Fujiki Y, Sano H, Oda M, Yaginuma K, Kobayashi M, Koike K (1989) The X gene of hepatitis B virus induced growth stimulation and tumorigenic transformation of mouse NIH3T3 cells. Jpn J Cancer Res 80:617-621
232. Simons MJ, Yu M, Chew BK, Tan AY, Yap EH, Seah CS, Fung WP, Shanmugaratnam K (1971) Australia antigen in Singapore Chinese patients with hepatocellular carcinoma. Lancet 1:1149-1151
233. Sirma H, Giannini C, Poussin K, Paterlini P, Kremsdorf D, Brechot C (1999). Hepatitis B virus X mutants, present in hepatocellular carcinoma tissue abrogate both the antiproliferative and transactivation effects of HBx. Oncogene 18:4848-4859
234. Sitterlin D, Bergametti F, Transy C (2000). UVDDB p127-binding modulates activities and intracellular distribution of hepatitis B virus X protein. Oncogene 19:4417-4426
235. Slagle BL, Lee TH, Medina D, Finegold MJ, Butel JS (1996). Increased sensitivity to the hepatocarcinogen diethylnitrosamine in transgenic mice carrying the hepatitis B virus X gene. Mol Carcinog 15:261-269
236. Smith JA, Francis TI (1972). Immunoepidemiological and in vitro studies of possible relationships between Australia antigen and hepatocellular carcinoma. Cancer Res 32:1713-1720
237. Spandau DF, Lee CH (1988). trans-activation of viral enhancers by the hepatitis B virus X protein. J Virol 62:427-434
238. Sprengel R, Kaleta EF, Will H (1988). Isolation and characterization of a hepatitis B virus endemic in herons. J Virol 62:3832-3839
239. Staprans S, Loeb DD, Ganem D (1991). Mutations affecting hepadnavirus plus-strand DNA synthesis dissociate primer cleavage from translocation and reveal the origin of linear viral DNA. J Virol 65:1255-1262
240. Studach LL, Rakotomalala L, Wang WH, Hullinger RL, Cairo S, Buendia MA, Andrisani OM (2009). Polo-like kinase 1 inhibition suppresses hepatitis B virus X protein-induced transformation in an in vitro model of liver cancer progression. Hepatology 50:414-423
241. Su F, Schneider RJ (1997). Hepatitis B virus HBx protein sensitizes cells to apoptotic killing by tumor necrosis factor alpha. Proc Natl Acad Sci USA 94:8744-8749
242. Su Q, Schroder CH, Hofmann WJ, Otto G, Pichlmayr R, Bannasch P (1998). Expression of hepatitis B virus X protein in HBV-infected human livers and hepatocellular carcinomas. Hepatology 27:1109-1120
243. Summers J, Mason WS (1982). Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate. Cell 29:403-415
244. Summers J, O'Connell A, Maupas P, Goudeau A, Coursaget P, Drucker J (1978a). Hepatitis B virus DNA in primary hepatocellular carcinoma tissue. J Med Virol 2:207-214
245. Summers J, Smolec JM, Snyder R (1978b). A virus similar to human hepatitis B virus associated with hepatitis and hepatoma in woodchucks. Proc Natl Acad Sci USA 75:4533-7453
246. Summers J, Smith PM, Horwich AL (1990). Hepadnavirus envelope proteins regulate covalently closed circular DNA amplification. J Virol 64:2819-2824
247. Summers J, Jilbert AR, Yang W, Aldrich CE, Saputelli J, Litwin S, Toll E, Mason WS (2003) Hepatocyte turnover during resolution of a transient hepadnaviral infection. Proc Natl Acad Sci USA 100:11652-11659
248. Sun YL, Yin SY, Xie HY, Zhou L, Xue F, Wu LM, Gao F, Zheng SS (2008). Stem-like cells in hepatitis B virus-associated cirrhotic livers and adjacent tissue to hepatocellular carcinomas possess the capacity of tumorigenicity. J Gastroenterol Hepatol 23:1280-1286
249. Tamura I, Kurimura O, Koda T, Ichimura H, Katayama S, Kurimura T, Inaba Y (1993). Risk of liver cirrhosis and hepatocellular carcinoma in subjects with hepatitis B and delta virus infection: a study from Kure, Japan. J Gastroenterol Hepatol 8:433-436
250. Tanaka Y, Kanai F, Kawakami T, Tateishi K, Ijichi H, Kawabe T, Arakawa Y, Kawakami T, Nishimura T, Shirakata Y, Koike K, Omata M (2004). Interaction of the hepatitis B virus X protein (HBx) with heat shock protein 60 enhances HBx-mediated apoptosis. Biochem Biophys Res Commun 318:461-469
251. Tang W, Lazaro CA, Campbell JS, Parks WT, Katze MG, Fausto N (2007). Responses of nontransformed human hepatocytes to conditional expression of full-length hepatitis C virus open reading frame. Am J Pathol 171:1831-1846
252. Teratani T, Ishikawa T, Shiratori Y, Shiina S, Yoshida H, Imamura M, Obi S, Sato S, Hamamura K, Omata M (2002). Hepatocellular carcinoma in elderly patients: beneficial therapeutic efficacy using percutaneous ethanol injection therapy. Cancer 95:816-823
253. Teres J, Guardia J, Bruguera M, Rodes J (1971). Hepatitis-associated antigen and hepatocellular carcinoma. Lancet 2:215
254. Terradillos O, Pollicino T, Lecoeur H, Tripodi M, Gougeon ML, Tiollais P, Buendia MA (1998) p53-independent apoptotic effects of the hepatitis B virus HBx protein in vivo and in vitro. Oncogene 17:2115-2123
255. Terradillos O, de La Coste A, Pollicino T, Neuveut C, Sitterlin D, Lecoeur H, Gougeon ML, Kahn A, Buendia MA (2002). The hepatitis B virus X protein abrogates Bcl-2-mediated protection against Fas apoptosis in the liver. Oncogene 21:377-386
256. Thimme R, Wieland S, Steiger C, Ghrayeb J, Reimann KA, Purcell RH, Chisari FV (2003). CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. J Virol 77:68-76
257. Thorgeirsson SS, Grisham JW (2002). Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 31:339-346
258. Tong MJ, Sun SC, Schaeffer BT, Chang NK, Lo KJ, Peters RL (1971). Hepatitis-associated antigen and hepatocellular carcinoma in Taiwan. Ann Intern Med 75:687-691
259. Toshkov I, Hacker HJ, Roggendorf M, Bannasch P (1990). Phenotypic patterns of preneoplastic and neoplastic hepatic lesions in woodchucks infected with woodchuck hepatitis virus. J Cancer Res Clin Oncol 116:581-590
260. Transy C, Fourel G, Robinson WS, Tiollais P, Marion PL, Buendia MA (1992). Frequent amplification of c-myc in ground squirrel liver tumors associated with past or ongoing infection with a hepadnavirus. Proc Natl Acad Sci USA 89:3874-3878
261. Transy C, Renard CA, Buendia MA (1994). Analysis of integrated ground squirrel hepatitis virus and flanking host DNA in two hepatocellular carcinomas. J Virol 68:5291-5295
262. Tu H, Bonura C, Giannini C, Mouly H, Soussan P, Kew M, Paterlini-Brechot P, Brechot C, Kremsdorf D (2001). Biological impact of natural COOH-terminal deletions of hepatitis B virus X protein in hepatocellular carcinoma tissues. Cancer Res 61:7803-7810
263. Tuttleman JS, Pourcel C, Summers J (1986a). Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells. Cell 47:451-460
264. Tuttleman JS, Pugh JC, Summers JW (1986b). In vitro experimental infection of primary duck hepatocyte cultures with duck hepatitis B virus. J Virol 58:17-25
265. Twu JS, Schloemer RH (1987). Transcriptional trans-activating function of hepatitis B virus. J Virol 61:3448-3453
266. Twu JS, Lai MY, Chen DS, Robinson WS (1993). Activation of protooncogene c-jun by the X protein of hepatitis B virus. Virology 192:346-350
267. Ueda K, Wei Y, Ganem D (1996). Activation of N-myc2 gene expression by cis-acting elements of oncogenic hepadnaviral genomes: key role of enhancer II. Virology 217:413-417
268. Velasco M, Sorensen R, Daiber A, Carmona A, Katz R (1971). Primary carcinoma of the liver associated with Australia antigen. Lancet 1:1183-1184
269. Verme G, Brunetto MR, Oliveri F, Baldi M, Forzani B, Piantino P, Ponzetto A, Bonino F (1991) Role of hepatitis delta virus infection in hepatocellular carcinoma. Dig Dis Sci 36:1134-1136
270. Vogel CL, Anthony PP, Sadikali F, Barker LF, Peterson MR (1972). Hepatitis-associated antigen and antibody in hepatocellular carcinoma: results of a continuing study. J Natl Cancer Inst 48:1583-1588
271. Volz T, Lutgehetmann M, Wachtler P, Jacob A, Quaas A, Murray JM, Dandri M, Petersen J (2007) Impaired intrahepatic hepatitis B virus productivity contributes to low viremia in most HBeAgnegative patients. Gastroenterology 133:843-852
272. Wang N, Sun Z, Pang Q, Xia Q (1980). Liver cancer, liver disease background and virus-like particles in serum among ducks from high incidence area of human hepatocellular carcinoma. Clin J Oncol 2:176-178
273. Wang J, Chenivesse X, Henglein B, Brechot C (1990). Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma. Nature 343:555-557
274. Wang XW, Gibson MK, Vermeulen W, Yeh H, Forrester K, Sturzbecher HW, Hoeijmakers JH, Harris CC (1995). Abrogation of p53-induced apoptosis by the hepatitis B virus X gene. Cancer Res 55:6012-6016
275. Wang HD, Trivedi A, Johnson DL (1998). Regulation of RNA polymerase I-dependent promoters by the hepatitis B virus X protein via activated Ras and TATA-binding protein. Mol Cell Biol 18:7086-7094
276. Wang HC, Wu HC, Chen CF, Fausto N, Lei HY, Su IJ (2003). Different types of ground glass hepatocytes in chronic hepatitis B virus infection contain specific pre-S mutants that may induce endoplasmic reticulum stress. Am J Pathol 163:2441-2449
277. Wang HC, Chang WT, Chang WW, Wu HC, Huang W, Lei HY, Lai MD, Fausto N, Su IJ (2005) Hepatitis B virus pre-S2 mutant upregulates cyclin A expression and induces nodular proliferation of hepatocytes. Hepatology 41:761-770
278. Wang HC, Huang W, Lai MD, Su IJ (2006). Hepatitis B virus pre-S mutants, endoplasmic reticulum stress and hepatocarcinogenesis. Cancer Sci 97:683-688
279. Wang HY, Chien MH, Huang HP, Chang HC, Wu CC, Chen PJ, Chang MH, Chen DS (2010) Distinct hepatitis B virus dynamics in the immunotolerant and early immunoclearance phases. J Virol 84:3454-3463
280. Ward SC, Thung SN, Lim KH, Tran TT, Hong TK, Hoang PL, Jang JJ, Park YN, Abe K (2010) Hepatic progenitor cells in liver cancers from Asian children. Liver Int 30:102-111
281. Waris G, Huh KW, Siddiqui A (2001). Mitochondrially associated hepatitis B virus X protein constitutively activates transcription factors STAT-3 and NF-kappa B via oxidative stress. Mol Cell Biol 21:7721-7730
282. Wei Y, Ponzetto A, Tiollais P, Buendia MA (1992). Multiple rearrangements and activated expression of c-myc induced by woodchuck hepatitis virus integration in a primary liver tumour. Res Virol 143:89-96
283. Wei Y, Tavis JE, Ganem D (1996). Relationship between viral DNA synthesis and virion envelopment in hepatitis B viruses. J Virol 70:6455-6458
284. Wentz MJ, Becker SA, Slagle BL (2000). Dissociation of DDB1-binding and transactivation properties of the hepatitis B virus X protein. Virus Res 68:87-92
285. Werle-Lapostolle B, Bowden S, Locarnini S, Wursthorn K, Petersen J, Lau G, Trepo C, Marcellin P, Goodman Z, Delaney WE, Xiong S, Brosgart CL, Chen SS, Gibbs CS, Zoulim F (2004) Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy. Gastroenterology 126:1750-1758
286. Wieland S, Thimme R, Purcell RH, Chisari FV (2004a). Genomic analysis of the host response to hepatitis B virus infection. Proc Natl Acad Sci USA 101:6669-6674
287. Wieland SF, Spangenberg HC, Thimme R, Purcell RH, Chisari FV (2004b). Expansion and contraction of the hepatitis B virus transcriptional template in infected chimpanzees. Proc Natl Acad Sci USA 101:2129-2134
288. Wild CP, Gong YY (2010). Mycotoxins and human disease: a largely ignored global health issue. Carcinogenesis 31:71-82
289. Wolf HK, Michalopoulos GK (1992). Hepatocyte regeneration in acute fulminant and nonfulminant hepatitis: a study of proliferating cell nuclear antigen expression. Hepatology 15:707-713
290. Wynne SA, Crowther RA, Leslie AG (1999). The crystal structure of the human hepatitis B virus capsid. Mol Cell 3:771-780
291. Xu Z, Jensen G, Yen TS (1997). Activation of hepatitis B virus S promoter by the viral large surface protein via induction of stress in the endoplasmic reticulum. J Virol 71:7387-7392
292. Xu Z, Yen TS, Wu L, Madden CR, Tan W, Slagle BL, Ou JH (2002). Enhancement of hepatitis B virus replication by its X protein in transgenic mice. J Virol 76:2579-2584
293. Yaginuma K, Kobayashi H, Kobayashi M, Morishima T, Matsuyama K, Koike K (1987). Multiple integration site of hepatitis B virus DNA in hepatocellular carcinoma and chronic active hepatitis tissues from children. J Virol 61:1808-1813
294. Yamashita T, Honda M, Nio K, Nakamoto Y, Takamura H, Tani T, Zen Y, Kaneko S (2010) Oncostatin m renders epithelial cell adhesion molecule-positive liver cancer stem cells sensitive to 5-Fluorouracil by inducing hepatocytic differentiation. Cancer Res 70:4687-4697
295. Yang W, Summers J (1998). Infection of ducklings with virus particles containing linear double-stranded duck hepatitis B virus DNA: illegitimate replication and reversion. J Virol 72:8710-8717
296. Yang W, Summers J (1999). Integration of hepadnavirus DNA in infected liver: evidence for a linear precursor. J Virol 73:9710-9717
297. Yang D, Alt E, Rogler CE (1993). Coordinate expression of N-myc 2 and insulin-like growth factor II in precancerous altered hepatic foci in woodchuck hepatitis virus carriers. Cancer Res 53:2020-2027
298. Yang D, Faris R, Hixson D, Affigne S, Rogler CE (1996a). Insulin-like growth factor II blocks apoptosis of N-myc2-expressing woodchuck liver epithelial cells. J Virol 70:6260-6268
299. Yang W, Mason WS, Summers J (1996b). Covalently closed circular viral DNA formed from two types of linear DNA in woodchuck hepatitis virus-infected liver. J Virol 70:4567-4575
300. Yang JC, Teng CF, Wu HC, Tsai HW, Chuang HC, Tsai TF, Hsu YH, Huang W, Wu LW, Su IJ (2009). Enhanced expression of vascular endothelial growth factor-A in ground glass hepatocytes and its implication in hepatitis B virus hepatocarcinogenesis. Hepatology 49:1962-1971
301. Yao E, Gong Y, Chen N, Tavis JE (2000). The majority of duck hepatitis B virus reverse transcriptase in cells is nonencapsidated and is bound to a cytoplasmic structure. J Virol 74:8648-8657
302. Yeh SH, Chen PJ, Shau WY, Chen YW, Lee PH, Chen JT, Chen DS (2001). Chromosomal allelic imbalance evolving from liver cirrhosis to hepatocellular carcinoma. Gastroenterology 121:699-709
303. Yim HJ, Lok AS (2006). Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005. Hepatology 43:S173-S181
304. Yoo YD, Ueda H, Park K, Flanders KC, Lee YI, Jay G, Kim SJ (1996). Regulation of transforming growth factor-beta 1 expression by the hepatitis B virus (HBV) X transactivator. Role in HBV pathogenesis. J Clin Invest 97:388-395
305. Yotsuyanagi H, Yasuda K, Iino S, Moriya K, Yoshizumi Y, Fujie H, Tsutsumi T, Kimura S, Koike K (1997). Persistent viremia after recovery from self-limited acute hepatitis B. Hepatology 27:1377-1382
306. Yu X, Mertz JE (1996). Promoters for synthesis of the pre-C and pregenomic mRNAs of human hepatitis B virus are genetically distinct and differentially regulated. J Virol 70:8719-8726
307. Yu FL, Liu HJ, Lee JW, Liao MH, Shih WL (2005). Hepatitis B virus X protein promotes cell migration by inducing matrix metalloproteinase-3. J Hepatol 42:520-527
308. Yuan TT, Lin MH, Chen DS, Shih C (1998). A defective interference-like phenomenon of human hepatitis B virus in chronic carriers. J Virol 72:578-584
309. Yuan TT, Sahu GK, Whitehead WE, Greenberg R, Shih C (1999). The mechanism of an immature secretion phenotype of a highly frequent naturally occurring missense mutation at codon 97 of human hepatitis B virus core antigen. J Virol 73:5731-5740
310. Yuen MF, Tanaka Y, Fong DY, Fung J, Wong DK, Yuen JC, But DY, Chan AO, Wong BC, Mizokami M, Lai CL (2009). Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B. J Hepatol 50:80-88
311. Zhang Z, Torii N, Hu Z, Jacob J, Liang TJ (2001). X-deficient woodchuck hepatitis virus mutants behave like attenuated viruses and induce protective immunity in vivo. J Clin Invest 108:1523-1531
312. Zhang SM, Sun DC, Lou S, Bo XC, Lu Z, Qian XH, Wang SQ (2005a). HBx protein of hepatitis B virus (HBV) can form complex with mitochondrial HSP60 and HSP70. Arch Virol 150:1579-1590
313. Zhang X, Dong N, Yin L, Cai N, Ma H, You J, Zhang H, Wang H, He R, Ye L (2005b). Hepatitis B virus X protein upregulates survivin expression in hepatoma tissues. J Med Virol 77:374-381
314. Zhang X, Dong N, Zhang H, You J, Wang H, Ye L (2005c). Effects of hepatitis B virus X protein on human telomerase reverse transcriptase expression and activity in hepatoma cells. J Lab Clin Med 145:98-104
315. Zhang R, Wang L, Yang AG (2009). Is microRNA-143 really a turncoat of tumor suppressor microRNA in hepatitis B virus-related hepatocellular carcinoma? Hepatology 50:987
316. Zheng Y, Chen WL, Louie SG, Yen TS, Ou JH (2007). Hepatitis B virus promotes hepatocarcinogenesis in transgenic mice. Hepatology 45:16-21
317. Zhu Y, Yamamoto T, Cullen J, Saputelli J, Aldrich CE, Miller DS, Litwin S, Furman PA, Jilbert AR, Mason WS (2001). Kinetics of hepadnavirus loss from the liver during inhibition of viral DNA synthesis. J Virol 75:311-322
318. Zhu H, Wang Y, Chen J, Cheng G, Xue J (2004). Transgenic mice expressing hepatitis B virus X protein are more susceptible to carcinogen induced hepatocarcinogenesis. Exp Mol Pathol 76:44-50
319. Zlotnick A, Cheng N, Stahl SJ, Conway JF, Steven AC, Wingfield PT (1997). Localization of the C terminus of the assembly domain of hepatitis B virus capsid protein: implications for morphogenesis and organization of encapsidated RNA. Proc Natl Acad Sci USA 94:9556-9561
320. Zoulim F, Saputelli J, Seeger C (1994). Woodchuck hepatitis virus X protein is required for viral infection in vivo. J Virol 68:2026-2030